ME (Myalgic Encephalomyelitis) – UK Parliamentary Questions and Answers (May and June 2026 Summary)
Major Investment in ME/CFS Research
The UK Government has announced a £4.75 million investment in the new SequenceME programme, one of the largest genetic studies ever undertaken for ME/CFS. The project will analyse the genomes of up to 6,000 people with ME/CFS and aims to identify biological causes of the condition, improve diagnosis, and support the development of future treatments.
This work builds on the earlier DecodeME study and represents a significant step forward for ME/CFS research in the UK.
Progress on the ME/CFS Delivery Plan
The Government reports that substantial progress has been made on the commitments contained within the 2025 ME/CFS Delivery Plan. Many actions have already been completed or are underway, with work continuing across research, education, awareness, and patient support.
The plan focuses on three main objectives:
- Expanding research into ME/CFS.
- Improving understanding and education among healthcare professionals.
- Strengthening support and services for people living with ME/CFS.
Education and Awareness
A new NHS e-learning programme has been developed to help healthcare professionals improve their understanding of ME/CFS, including severe and very severe ME.
Medical schools across the UK are also being encouraged to increase awareness of the condition and provide students with opportunities to learn directly from people living with ME/CFS.
Work is also continuing on a public awareness campaign involving patient groups, charities, and individuals with lived experience of the illness.
Improving NHS Services
A national template service specification is being developed to help improve ME/CFS services across England. The aim is to provide clearer guidance for local NHS organisations and reduce regional differences in care.
However, responsibility for commissioning services remains with local Integrated Care Boards, which means service availability may continue to vary between areas.
Severe and Very Severe ME
A major topic during May and June was the lack of specialist support for people with severe and very severe ME.
Concerns were raised in Parliament about delays to plans for specialised services, with consideration of a dedicated national service now postponed until at least April 2027.
Patient groups, carers, and parliamentarians highlighted the challenges faced by many severely affected individuals, including difficulties accessing appropriate healthcare, nutrition support, and specialist expertise.
The Government has stated that interim measures are being considered while longer-term service proposals are developed.
Continuing Challenges
Despite recent progress, significant challenges remain:
- Unequal access to services across the country.
- Limited awareness of ME/CFS within some parts of the healthcare system.
- Delays in specialist support for severe and very severe patients.
- Historically low levels of research funding relative to the scale of the condition.
- Incomplete data on the number and severity of people living with ME/CFS.
Conclusion
May and June 2026 brought encouraging developments for the ME/CFS community, particularly through major new research funding and continued implementation of the Government’s ME/CFS Delivery Plan. Progress is being made in research, professional education, and service development. However, concerns remain about access to care, support for those with severe illness, and the pace of service improvements. Patient organisations continue to call for increased investment, faster implementation of specialist services, and stronger support throughout the NHS.